Pentagon awards blood technology contract to Terumo BCT

10/24/2013 | American City Business Journals

Terumo BCT has secured a Defense Department contract worth up to $29.9 million to improve its pathogen reduction technologies. Funding will help the company seek FDA approval of its Mirasol system and support testing and clinical trials. Terumo BCT will collaborate with the Army Medical Research and Material Command.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA